BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20132796)

  • 1. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
    Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
    Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
    Wood RC; Wyatt JE; Bullins KW; Hanley AV; Hanley GA; Denham JW; Panus PC; Harirforoosh S
    Eur J Pharmacol; 2013 Nov; 720(1-3):138-46. PubMed ID: 24365796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
    Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
    Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
    Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
    Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
    J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions.
    Takaishi O; Arakawa T; Yamasaki K; Fujiwara Y; Uchida T; Tominaga K; Watanabe T; Higuchi K; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):78S-82S. PubMed ID: 9753231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells.
    Tsutsumi S; Namba T; Tanaka KI; Arai Y; Ishihara T; Aburaya M; Mima S; Hoshino T; Mizushima T
    Oncogene; 2006 Feb; 25(7):1018-29. PubMed ID: 16205636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats.
    Murakami K; Okajima K; Uchiba M; Harada N; Johno M; Okabe H; Takatsuki K
    Dig Dis Sci; 1997 Feb; 42(2):319-25. PubMed ID: 9052513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
    Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib or diclofenac hepatic status in the presence or absence of rebamipide.
    Murrell DE; Rahmasari Y; Denham JW; Panus PC; Harirforoosh S
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3318-25. PubMed ID: 26400540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis.
    Moon SJ; Park JS; Jeong JH; Yang EJ; Park MK; Kim EK; Park SH; Kim HY; Cho ML; Min JK
    Arch Pharm Res; 2013 Jan; 36(1):116-24. PubMed ID: 23338062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
    Udagawa A; Shiota G; Ichiba M; Murawaki Y
    Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells.
    Joh T; Takezono Y; Oshima T; Sasaki M; Seno K; Yokoyama Y; Ohara H; Nomura T; Alexander JS; Itoh M
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():133-8. PubMed ID: 12925151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa.
    Suetsugu H; Ishihara S; Moriyama N; Kazumori H; Adachi K; Fukuda R; Watanabe M; Kinoshita Y
    J Lab Clin Med; 2000 Jul; 136(1):50-7. PubMed ID: 10882227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
    Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
    Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
    Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.